Utah Medical Products 2Q FY26 net income falls 11.9% to USD 2.69 million; net sales drop 14.3% to USD 8.53 million

Reuters2026/08/12 18:01

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Utah Medical Products posted 2Q 2026 net income of USD 2.69 million, down 11.9% year over year; diluted EPS fell 10.1% to USD 0.84.
Net sales dropped 14.3% to USD 8.53 million; management cited no sales to two previously largest customers.
Operating income slid 17.1% to USD 2.65 million; operating margin narrowed 1 percentage point to 31.1%.
Gross profit edged down 15% to USD 4.76 million; gross margin tightened 0.4 percentage point to 55.8% on Filshie device tariffs.
Management projected full-year 2026 net sales to decline 10%-13% versus 2025, citing slower-than-expected new biopharma OEM customer sales.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Utah Medical Products Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001096906-26-001210), on August 12, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Utah Medical Products 2Q FY26 net income falls 11.9% to USD 2.69 million; net sales drop 14.3% to USD 8.53 million

You may also like

Crypto prices